期刊文献+

冠心病与外周动脉硬化的相关性研究 被引量:1

Study of relationship between coronary heart disease and peripheral arteriosclerosis
下载PDF
导出
摘要 目的:以超声观测颈动脉(CA)、股动脉(FA)、髂总动脉(CIA)和胸部X线片观测主动脉弓(AA)的动脉硬化(AS),评价其与冠心病(CHD)之间的关联性。方法:对74例冠状动脉造影(CAG)受检者行体表动脉超声及胸部X线片检测,观测CA、FA、CIA及AA的AS,并以此同CAG结果进行比较分析。结果:(1)CHD组病例外周动脉IMT比对照组显著增厚(P<0.05);(2)CHD组与对照组间外周动脉斑块检出率差异显著(P<0.05)。(3)半定量斑块级别增加与冠脉病变增加之间显著相关(P<0.05)。(4)CHD组与对照组间AA钙化检出率差异显著(P<0.05);(5)CA斑块、FA斑块、CIA斑块和AA钙化联合检测来评价CHD的价值高于单独检测。结论:外周动脉AS和AA钙化的检测有助于对CHD的总体评估。胸部X线片可用于检测AA钙化,而高分辨率超声是检测外周动脉AS的有效方法。 Objective:The arteriosclerosis(AS) of carotid artery(CA),femoral artery(FA),common iliac artery(CIA) and aortic arch(AA) were observed by ultraso-nography or chest X-ray respectively to evaluate their relationship with coronary heart disease(CHD).Methods:74 cases undergoing coronary angiography(CAG) were checked by ultrasonography and chest X-ray respectively to observe the case of AS of CA,FA,CIA and AA,which were analyzed with the results of CAG.Results:(1) Intima-media thickness(IMT) of peripheral arteries of cases in CHD group were more thickened than the ones in control group significantly(P 0.05).(2) Proportions of AS plaques detected in peripheral arteries were significantly different between CHD group and control group(P 0.05).(3) Semiquantitative AS plaque classification increased with the number of stenosed coronary branches(P 0.05).(4) Proportions of objects with AA calcification between CHD group and control group were significantly different(P 0.05).(5) CHD was evaluated by CA plaque,FA plaque,CIA plaque and AA calcification jointly had greater value than respectively.Conclusions:Peripheral arterial AS and AA calcification contribute to the overall evaluation of CHD.Chest X-ray can be used to detect AA calcification,while high-resolution ultrasonography is an effective meth-od for the detection of peripheral AS.
出处 《东南大学学报(医学版)》 CAS 2010年第4期377-381,共5页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金资助项目(30840042)
关键词 外周动脉 动脉硬化 斑块 钙化 冠状动脉硬化性心脏病 peripheral artery arteriosclerosis arteriosclerosis plaque calcification coronary heart disease
  • 相关文献

参考文献10

  • 1LEKAKIS J P,PAPAMICHAEL C M,CIMPONERIU A T,et al.Atherosc-lerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis[J].Am J Cardiol,2000,85(8):949-952.
  • 2虞旭东,傅国胜,鲍晓锋,郑浩.颈、股动脉粥样硬化超声标识与冠心病的关系研究[J].临床心血管病杂志,2006,22(8):490-492. 被引量:9
  • 3许竹梅,赵水平,范平.超声测量颈动脉内膜中层厚度与颈动脉斑块的关系[J].中国动脉硬化杂志,2000,8(2):165-168. 被引量:196
  • 4RIETZSCHEL E R,DEBUYZERE M L,DUPREZ D A,et al.Interchangeability of carotid and femoral intima-media thickness in risk stratification[J].Int Angiol,2001,20(1):38.
  • 5AKOSAH K O.MCHUGH V L,BARNHART S I,et al.Carotid ultraso-und for risk clarification in young to middle-aged adults undergoing elective coronary angiography[J].Am J Hypertens,2006,19(12):1256-1261.
  • 6KATSUYA I,HIROKO H,MASAYOSHI H,et al.Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors[J].Atherosclerosis,2010,210(1):137-144.
  • 7IRIBARREN C,SIDNEY S,STERNFELD B,et al.Calcification of the aortic arch:risk factors and association with coronary heart disease,stroke and peripheral vascular disease[J].JAMA,2000,283(21):2810-2815.
  • 8MECULLOUGH P A,SOMAN S.Cardiovascular calcification in patients with chronic renal failure:are we on target with this risk factor?[J].Kidney Int,2004,66(90):18-24.
  • 9TAYLOR A J,BINDEMAN J,LE T P,et al.Progression of calcified coronary atherosclerosis:relationship to coronary risk factors and carotid intima-media thickness[J].Atherosclerosis,2008,197(1):339-345.
  • 10WATANABE K,HIROKI T,KOGA N,et al.Relation of thoracic aorta calcification on compated tomography and coronary risk factors to obstructive coronary coronary artery disease on angiography[J].Angiology,2003,54(4):433-441.

二级参考文献11

  • 1黄铮,乐玮,陶蓉,李玲,龚兰生.急性心肌梗塞患者心率变异性的初步分析[J].临床心血管病杂志,1996,12(2):98-99. 被引量:8
  • 2Skoglund C,Arterioscler Thromb Vasc Biol,1999年,19期,2422页
  • 3GARIEPY J, MASSONEAU M, LEVENSON J, etal. Evidence for in vivo carotid and femoral wall thickening in human hypertension[J]. Hypertension,1993,22:111--118.
  • 4FEINSTEIN S B, VOCI P, PIZZUTO F. Noninvasive surrogate markers of atherosclerosis[J]. Am J Cardiol, 2002,89 : 31C-43C.
  • 5ROSS R. The pathogenesis of Atherosclerosis: a perspective for the 1990s[J]. Nature, 1993,362:802--809.
  • 6PIGNOLI P, TREMOLI E, POLl A, et al. Intima plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging[J]. Circulation, 1986,74:1399--1406.
  • 7CROUSE Ⅲ J R,TANG R, ESPELAND M A, et al.Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease[J].Circulation, 2002 , 106 : 2061 -- 2066.
  • 8GLAGOV S, ZARINS C, GIDDENS D P, et al. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries[J].Arch Pathol Lab Med,1988,112:1018--1031.
  • 9SMEDBY O. Geometrical risk factors for atherosclerosis in the fermoal artery: a longitudinal angiographic study[J]. Ann Biomed Eng, 1998,26:391--397.
  • 10LEKAKIS J P, PAPAMICHAEL C M, CIMPONERIU A T, et al. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis[J]. Am J Cardiol, 2000, 85 : 949--952.

共引文献202

同被引文献7

  • 1马文君,刘国仗.老年人高血压靶器官损害特点[J].中华老年医学杂志,2005,24(4):255-255. 被引量:13
  • 2王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 3Oliver M J, Edwards L J, Churchill D N. Impact of sodium and ultrafihration profiling on hemodialysis-related symptoms [ J ]. J Am Soe Nephro1,2001,12 : 151-156.
  • 4Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on dialysis strategies[ J]. Nephrol Dial Trans,2007,22:5-21.
  • 5Annis M Mamey,Ti Ma,James M Luther,et al. Endogenous bradykinin contributes to increased plasminogen activator inhibitor I antigen follow hemodialysis[J]. J Am Soc Nephrol,2009,20:22d6-2252.
  • 6Iwanaga K, Takamura N, Abe Y, et al. Plasma concentrations of adrenomedulin and ghrelin in hemodialysls patients with sustained and episodic hypotension[ J]. Endocr J,2005,52 ( 1 ) :23-28.
  • 7Locatelli F,Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease [ J ]. J Am Soc Nephro1,2004,15 ( Suppl 1 ) : $25-29.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部